Антифосфолипидный синдром - Насонов Е.Л.
ISBN 5-98216-010-5
Скачать (прямая ссылка):
72. Hosenpud JD, Montanaro A, Hart MV: Myocardial perfusion abnormalities in asympto-
matic patients with systemic lupus erythematosus. Am J Med 1984, 77: 286—792.
73. Shome GP, Sakauchi M, Yamane K. Ischemic heart disease in systemic lupus erythematosus. A retrospective study of 65patients treated with prednisolone. Jpn J Med 1989; 28: 599— 603.
74. Bruce IN, Burns RJ, Gladman DD, Urowitz MB. A study of myocardial perfusion abnormalities in women with SLE. J Rheumatol 1998; 25(Suppl 52): 72.
75. Самойленко ЛЕ, Фомичева ОА, Насонов ЕЛ и соавт. Состояние микроциркуляции миокарда у больных системной красной волчанкой. Терапевт. архив, 2001; 5: 29—31.
76. Berman DS, Kiat H, Freidman JD. Separate acquisition rest thallium—201/technetium-99m sestamibi dual-isotope myocardial perfusion single-photon emission computed tomography: a clinical validation study. J Am Coll Cardiol 1993, 22:1455—1464.
77. San S-S, Shiau Y-X, Tsai S-C, et al. The role of technetion-99m setanibi myocardial perfusion single-photon emission computed tomography (SPECT) in the detection of cardiovascular involvement in systemic lupus erythematosus patients with non-specific chest complaints. Rheumatology 2001; 40: 1106—1111.
78. Schillaci O, Lagana B, Danieli R, et al. Technetiom-99m sestamibi single photon-emission tomography defects subclinical myocardial perfusion abnormalities in patients with systemic lupus erythematosus. Eur J Nucl Med 1999; 26: 713— 717.
79. Taquet A, Bonithon-Knopp C, Simon A, et al. Relations of cardiovascular risk factors to aortic pulse wave velocity is asymptomatic middle-aged women. Eur JEpidemiol 1993; 9:298—306.
80. SeilzerF, Sutton-TyrrellK, FitzgeraldS, et al. Vasculat stiffness in women with systemic lupus erythematosus. Hypertension 2001; 37: 1075— 1082.
81. Detrano RC, Wong ND, Doherty TM, et al. Coronary calcium does not accurately predict near-term future coronary events in hifh-risk adults. Circulation 1999: 2633—2638.
82. ORourke RA, Brundage BH, Froelicher VF, et al. ACC/AHA expert consensus document on electron-beam computed tomography for the
SHS-OOO4.qxd 21.11.2006 16:56 Page 3 3/2"
32
Насонов Е.Л. Антифосфолипидный синдром.
diagnosis and pognosis of coronary artery disease. Circulation 2000; 102: 126—140.
83. Park R, Detrano R, Xiang M, et al. Combined use of computed tomography coronary calcium score and C-reactive protein levels in predicting cardiovascular events in nondiabetic individuals. Circulation 2002; 10: 2073—2089.
84. Sherer Y, Shemesh J, Tenenbaum A, et al. Coronary calcium and anti-cardiolipin antibody are elevated in patients with typical chest pain. Am J Cardiol 2000; 86:1306—1311.
85. Scalzi LV, VonFeldt JM. Electrone Beam computer tomography as a tool to identification asymptomatic coronary atherosclerosis in SLE patients. ACR 64th Annual Scientific Meeting 2000; 33(abst).
86. Turner ELS, Oeser A. Asunuma Y, et al. Premature coronary atherosclerosis in systemic lupus erythematosus is not related in disease activity or corticosteroid rherapy. ACR 66th Annual Scientific Meeting, October 24—29, 2002; 36 (abst).
87. Petri M. Noninvasive test for atherosclerosis in SLE. ACR 65 th Annual Scientific Meeting, November 10—15, 2001; 1671 (abst).
88. Petri M. Cardiovascular risk factors and coronary calcification (CC) in systemic lupus erythematosus. ACR 65 th Annual Scientific Meeting, November 10—15, 2001; 1409 (abst).
89. Von Velt JM, Eisner ER, Sawaires A. Coronary electron beam computed tomography in 13patients with systemic lupus erythematosus and two or more cardiovascular risk factors. J Clin Rheumatol 2002; 8: 316—321.
90. Manger K, Kukus M, Foster C, et al. Risk factors for coronary-artery calcification in females with systemic lupus erythematosus below of age 50. ACR 65 th Annual Scientific Meeting November 10—15, 2001; 1408 (abst).
91. Flagg SD, Scalzi LV, van Dyke AL, et al. Homocystein and number of traditional cardiovascular risks predict coronary artery calcification in SLE. ACR/ARHP Annual Scientific Meeting October 24—28, 2003; 887 (abst).
92. Petri M, Kiani AN. Coronary calcium in SLE is due to inflammation, not lipid. ACR/ARHP Annual Scientific Meeting October 24—28, 2003; 889 (abst).
93. Lima DSN, Sato EI, Lima VC, et al. Brachial endothelial function is impaired in patients with systemic lupus erythematosus. J Rheumatol 2002; 29: 292—297.
94. De Lеeuw K, Freire B, Smith AJ, et al. Premature atherosclerosis and endothelial dysfunction in systemic lupus erythematosus. ACR 66th Annual Scientific Meeting October 25—29, 2002; 44 (abst).
95. Rajagopalan S, Somers E, Brook R, et al. Abnormal endothelial function in females with lupus correlates with circulating apoptotic endothelial cells. ACR/ARHP Annual Scientific Meeting October 24—28, 2003; 897 (abst).
96. Mancini J. Carotid intima-medis thickness as a measure of vascular target organ damage. Curr Hypertension Reports 2000; 2: 71—77.
97. OLeary DH, Polak JF, Kronman RA, et al. Carotide-artery intima media thickness as a risk factor for myocardial infarction and stroke in older adults. New Engl J Med 1999; 340:14—22.
